Sallevelt, Bastiaan T. G. M. http://orcid.org/0000-0003-4687-4048
Egberts, Toine C. G.
Huibers, Corlina J. A.
Ietswaart, Jimmy
Drenth-van Maanen, A. Clara
Jennings, Emma
O’Mahony, Cian
Jungo, Katharina Tabea
Feller, Martin
Rodondi, Nicolas
Sibille, François-Xavier
Spinewine, Anne
van Puijenbroek, Eugène P.
Wilting, Ingeborg
Knol, Wilma
Funding for this research was provided by:
Horizon 2020 (No 634238, No 634238)
Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (SNSF 320030_188549, No NFP74 407440_167465)
Swiss Re Foundation (15.0137)
Article History
Accepted: 4 September 2022
First Online: 1 November 2022
Declarations
:
: This work is part of the project “OPERAM: OPtimising thERapy to prevent Avoidable hospital admissions in the Multimorbid elderly” supported by the European Union's Horizon 2020 research and innovation program under the grant agreement No 634238, and by the Swiss State Secretariat for Education, Research and Innovation (SERI) under contract number 15.0137. The OPERAM project was also partially funded by the Swiss National Science Foundation (SNSF 320030_188549). The work of Katharina Tabea Jungo was supported by the Swiss National Science Foundation (SNSF), grant No NFP74 407440_167465. The opinions expressed herein are those of the authors and do not necessarily reflect the official views of the European Commission and the Swiss government. The funder of the study had no role in the study design, data collection, analysis and interpretation or writing of the report.
: Bastiaan T.G.M. Sallevelt, Toine C.G. Egberts, Corlina J.A. Huibers, Jimmy Ietswaart, A. Clara Drenth-van Maanen, Emma Jennings, Cian O’Mahony, Katharina Tabea Jungo, Martin Feller, Nicolas Rodondi, François-Xavier Sibille, Anne Spinewine, Eugène van Puijenbroek, Ingeborg Wilting and Wilma Knol have no conflicts of interest related to the content of this article.
: The OPERAM trial was approved by the independent research ethics committees at each participating site (lead ethics committee: Cantonal Ethics Committee Bern, Switzerland, ID 2016-01200; Medical Research Ethics Committee Utrecht, Netherlands, ID 15-522/D; Comité d’Ethique Hospitalo-Facultaire Saint-Luc-UCL: 2016/20JUL/347–Belgian registration No: B403201629175; Cork University Teaching Hospitals Clinical Ethics Committee, Cork, Republic of Ireland; ID ECM 4 (o) 07/02/17), and Swissmedic as the responsible regulatory authority.
: Written informed consent was obtained from the patients or their legal representatives before enrolment in the OPERAM trial.
: Not applicable.
: Data for this study will be made available to others in the scientific community upon request after publication. Data will be made available for scientific purposes for researchers whose proposed use of the data has been approved by a publication committee.
: The codes used to convert the Screening Tool of Older Person’s Prescriptions (STOPP) / Screening Tool to Alert doctors to Right Treatment (START) criteria version 2 into algorithms for use in clinical decision support systems have been previously published by Huibers CJA, Sallevelt BTGM, de Groot DA, et al [CitationRef removed]. The code that supports the findings of this study will be made available for scientific purposes for researchers whose proposed use of the data has been approved by a publication committee.
: Authorship eligibility is based on the ICMJE authorship criteria. The authors certify that they have participated in the aspects of conception and design (BS, CH, TE, EvP, IW, WK), acquisition and interpretation of data (all authors), drafting the article (BS, JI, TE, EvP, IW, WK) and revising it critically for important intellectual content (all authors). All authors have approved the final article.